What is this all about?
What we strive to do within the company is harness the large amount of computational power that is available currently, in order to tackle the complex landscape that characterizes early-stage drug discovery efforts. Using target-specific protocols, a talented team will look to weave together diverse techniques to yield novel lead compounds with desirable properties.